Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock
VHAQ.RT
VHAQ.RT was delisted on the 20th of February, 2024.
32 hedge funds and large institutions have $1.89M invested in Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock in 2022 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 9 reducing their positions, and 3 closing their positions.
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
3% more funds holding
Funds holding: 31 → 32 (+1)
35% less capital invested
Capital invested by funds: $2.89M → $1.89M (-$1M)
78% less repeat investments, than reductions
Existing positions increased: 2 | Existing positions reduced: 9
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ASM
ATW SPAC Management
New York
|
+$128K |
| 2 |
BCM
Bluefin Capital Management
New York
|
+$84.5K |
| 3 |
MP
Mangrove Partners
Greenwich,
Connecticut
|
+$75.5K |
| 4 |
LCM
Landscape Capital Management
Englewood,
New Jersey
|
+$17.7K |
| 5 |
SIA
SkyView Investment Advisors
Shrewsbury,
New Jersey
|
+$11.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PSAMP
P. Schoenfeld Asset Management (PSAM)
New York
|
-$101K |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$79.8K |
| 3 |
Blackstone Inc
New York
|
-$74K |
| 4 |
PC
Periscope Capital
Toronto,
Ontario, Canada
|
-$69K |
| 5 |
GCL
Glazer Capital LLC
New York
|
-$26K |
VHAQ.RT Hedge Fund Activity: Q1 2022 in Review
32 of the 6,360 institutional investors tracked by Wall St. Rank reported a position in Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock (VHAQ.RT) for Q1 2022, worth a combined $1.89M — down 35% from $2.89M a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new VHAQ.RT positions and 3 closed out — a net gain of 1 holder — while 2 added to existing stakes and 9 trimmed.
The largest buyer was ATW SPAC Management, opening a new position worth an estimated $128K. The largest seller was P. Schoenfeld Asset Management (PSAM), exiting entirely with an estimated $101K sold.
- 32 institutional investors held Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock (VHAQ.RT) as of Q1 2022, up from 31 in Q4 2021.
- Funds reported $1.89M of Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock stock for Q1 2022, down 35% quarter-over-quarter.
- 4 funds opened new Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock positions in Q1 2022 and 3 closed out, a net change of +1 holder.
- The largest Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock buyer in Q1 2022 was ATW SPAC Management, an estimated $128K added.
- The largest Viveon Health Acquisition Corp. Rights, each exchangeable into one-twentieth of a share of Common Stock seller in Q1 2022 was P. Schoenfeld Asset Management (PSAM), an estimated $101K sold.
Based on aggregated 13F filings for Q1 2022.